Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Roncero, C; Ryan, P; Littlewood, R; Macias, J; Ruiz, J; Seijo, P; Palma-Alvarez, RF; Vega, P.

Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder

Hepatic Medicine-Evidence and Research. 2019; 11: 1-10 Nº de citas: 11 [doi:10.2147/HMER.S187133]

Jimenez-Sousa, MA; Berenguer, J; Fernandez-Rodriguez, A; Medrano, LM; Aldamiz-Echevarria, T; Perez-Latorre, L; Diez, C; Martin-Vicente, M; Gutierrez-Rivas, M; Martinez, I; Resino, S.

Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study

INFECTION GENETICS AND EVOLUTION. 2019; 67: 112-120 Nº de citas: 3 [doi:10.1016/j.meegid.2018.10.008]

Crespo, J; Albillos, A; Buti, M; Calleja, JL; Samaniego, JG; Guerra, MH; Serrano, T; Turnes, J; Acin, E; Berenguer, J; Berenguer, M; Colom, J; Fernandez, I; Rodriguez, CF; Forns, X; Garcia, F; Granados, R; Lazarus, J; Molero, JM; Molina, E; Escanilla, FP; Pineda, JA; Rodriguez, M; Romero, M; Roncero, C; de la Hoya, PS; Antolin, GS.

Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. 2019; 111(11): 862-873 Nº de citas: 26 [doi:10.17235/reed.2019.6700/2019]

Salgado, M; Kwon, M; Galvez, C; Badiola, J; Nijhuis, M; Bandera, A; Balsalobre, P; Miralles, P; Buno, I; Martinez-Laperche, C; Vilaplana, C; Jurado, M; Clotet, B; Wensing, A; Martinez-Picado, J; Diez-Martin, JL; IciStem Consortium.

Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant

ANNALS OF INTERNAL MEDICINE. 2018; 169(10): 674-683 Nº de citas: 60 [doi:10.7326/M18-0759]

Garcia-Broncano, P; Medrano, LM; Berenguer, J; Gonzalez-Garcia, J; Jimenez-Sousa, MA; Carrero, A; Hontanon, V; Guardiola, JM; Crespo, M; Quereda, C; Sanz, J; Garcia-Gomez, AB; Jimenez, JL; Resino, S; GESIDA 3603b Study Grp.

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status

Cells. 2018; 7(11): Nº de citas: 15 [doi:10.3390/cells7110196]

Garcia, M; Navarrete-Munoz, MA; Ligos, JM; Cabello, A; Restrepo, C; Lopez-Bernaldo, JC; de la Hera, FJ; Barros, C; Montoya, M; Fernandez-Guerrero, M; Estrada, V; Gorgolas, M; Benito, JM; Rallon, N.

CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control

Scientific Reports. 2018; 8: 15541-15541 Nº de citas: 11 [doi:10.1038/s41598-018-33749-5]

Nunez, JAP; Gonzalez-Garcia, J; Berenguer, J; Gallego, MJV; Loyarte, JAI; Metola, L; Bernal, E; Navarro, G; Del Amo, J; Jarrin, I.

Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

MEDICINE. 2018; 97(38): Nº de citas: 12 [doi:10.1097/MD.0000000000012238]

Berenguer, J; Alvarez, D; Dodero, J; Azcoaga, A.

HIV infection follow-up, organisational and management model

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36: 45-49 Nº de citas: 7 [doi:10.1016/S0213-005X(18)30247-7]

Moreno, S; Berenguer, J; Fuster-Ruizdeapodaca, MJ; Garcia Ontiveros M.

Early diagnosis

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36: 35-39 Nº de citas: 14 [doi:10.1016/S0213-005X(18)30245-3]

Alvaro-Meca, A; Ryan, P; Micheloud, D; De Miguel, A; Berenguer, J; Resino, S.

Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based study

Scientific Reports. 2018; 8: 12137-12137 Nº de citas: 6 [doi:10.1038/s41598-018-29739-2]

Rivero, A; Polo, R; Aldeguer, JL; Lozano, F; Antela, A; Arribas, JR; Asensi, V; Berenguer, J; Blanco, JR; Casado, JL; Clotet, B; Crespo, M; Domingo, P; Duenas, C; Gatell, JM; Gomez-Sirvent, JL; Gonzalez-Garcia, J; Iribarren, JA; de Quiros, JCLB; Cortes, LFL; Losa, JE; Mallolas, J; Marino, A; Martinez, E; Miro, JM; Moreno, S; Palacios, R; Pasquau, J; Pineda, JA; Podzamczer, D; Portilla, J; Poveda, E; Pulido, F; Rubio, R; Santos, J; Moreno, JS; Sanz, JS; Tellez, MJ; de la Torre, J; Tuset, M; Molina, JAP; AIDS Study Grp GESIDA Span.

Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017)

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(7): 435-445 Nº de citas: 4 [doi:10.1016/j.eimc.2017.04.001]

Cuypers, L; Perez, AB; Chueca, N; Aldamiz-Echevarria, T; Alados, JC; Martinez-Sapina, AM; Merino, D; Pineda, JA; Tellez, F; Espinosa, N; Salmeron, J; Rivero-Juarez, A; Vivancos, MJ; Hontanon, V; Vandamme, AM; Garcia, F.

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis

PLoS One. 2018; 13(7): Nº de citas: 12 [doi:10.1371/journal.pone.0201268]

Berenguer, J; Gil-Martin, A; Jarrin, I; Moreno, A; Dominguez, L; Montes, M; Aldamiz-Echevarria, T; Tellez, MJ; Santos, I; Benitez, L; Sanz, J; Ryan, P; Gaspar, G; Alvarez, B; Losa, JE; Torres-Perea, R; Barros, C; San Martin, JV; Arponen, S; de Guzman, MT; Monsalvo, R; Vegas, A; Garcia-Benayas, MT; Serrano, R; Gotuzzo, L; Menendez, MA; Belda, LM; Malmierca, E; Calvo, MJ; Cruz-Martos, E; Gonzalez-Garcia, JJ.

All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findings

HEPATOLOGY. 2018; 68(1): 32-47 Nº de citas: 58 [doi:10.1002/hep.29814]

Medrano, LM; Garcia-Broncano, P; Berenguer, J; Gonzalez-Garcia, J; Jimenez-Sousa, MA; Guardiola, JM; Crespo, M; Quereda, C; Sanz, J; Canorea, I; Carrero, A; Hontanon, V; Munoz-Fernandez, MA; Resino, S; GESIDA 3603B Study Grp.

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients

AIDS. 2018; 32(9): 1095-1105 Nº de citas: 36 [doi:10.1097/QAD.0000000000001787]

Valencia, J; Ryan, P; Alvaro-Meca, A; Troya, J; Gutierrez, J; Cuevas, G; Moreno, S.

High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis

AIDS. 2018; 32(9): 1157-1163 Nº de citas: 3 [doi:10.1097/QAD.0000000000001806]

Jimenez-Sousa, MA; Gomez-Moreno, AZ; Pineda-Tenor, D; Medrano, LM; Sanchez-Ruano, JJ; Fernandez-Rodriguez, A; Artaza-Varasa, T; Saura-Montalban, J; Vazquez-Moron, S; Ryan, P; Resino, S.

The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design

PLoS One. 2018; 13(5): Nº de citas: 7 [doi:10.1371/journal.pone.0197115]

Perez-Latorre, L; Sanchez-Conde, M; Miralles, P; Lopez, JC; Parras, F; Tejerina, F; Aldamiz-Echevarria, T; Carrero, A; Diez, C; Ramirez, M; Gutierrez, I; Bellon, JM; Banares, R; Berenguer, J.

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis

BMC INFECTIOUS DISEASES. 2018; 18: 170-170 Nº de citas: 1 [doi:10.1186/s12879-018-3067-z]

Gonzalez-Baeza, A; Dolengevich-Segal, H; Perez-Valero, I; Cabello, A; Tellez, MJ; Sanz, J; Perez-Latorre, L; Bernardino, JI; Troya, J; De La Fuente, S; Bisbal, O; Santos, I; Arponen, S; Hontanon, V; Casado, JL; Ryan, P; U-SEX GESIDA 9416 Study.

Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study

AIDS PATIENT CARE AND STDS. 2018; 32(3): 112-118 Nº de citas: 108 [doi:10.1089/apc.2017.0263]